RESPIOSA
A simple, min-imally invasive surgically implanted solution to provide optimal therapy for tongue-based OSA. Respiosa prevents the tongue from collapsing into the airway when patients sleep on their backs. Designed and tested by world-class developers with ENT surgeons, the novel Respiosa implant system promises to deliver effective, durable and adjustable therapy.
RESPIOSA
Industry:
Health Care Home Health Care Medical Medical Device Personal Health
Founded:
2019-12-17
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Total Employee:
1+
Status:
Active
Total Funding:
0
Similar Organizations
MedTech Entrepreneurs (MTE)
MedTech Entrepreneurs is a venture capital fund.
Venous Stent BV
World’s first in length adjustable multi-segmented venous stent
Current Employees Featured
Investors List
NLC
NLC investment in Pre Seed Round - Respiosa